Clinical feasibility and safety of transoesophageal motor-evoked potential monitoring
Clinical feasibility and safety of transoesophageal motor-evoked potential monitoring
复制标题
DOI:
10.1093/ejcts/ezaa002
复制
发表时间:
2020-06-01
影响因子:
3.4
通讯作者:
Ohashi, Yuko
中科院分区:
文献类型:
--
作者:
Shiiya, Norihiko;Tsuda, Kazumasa;Ohashi, Yuko
OBJECTIVES: Canine experiments have shown that transoesophageal motor-evoked potential monitoring is feasible, safe and stable, with a quicker response to ischaemia and a better prognostic value than transcranial motor-evoked potentials. We aimed to elucidate whether or not these findings were clinically reproducible.METHODS: A bipolar oesophageal electrode mounted on a large-diameter silicon tube and a train of 5 biphasic wave stimuli were used for transoesophageal stimulation. Results of 18 patients (median age 74.5years, 13 males) were analysed.RESULTS: There were no mortalities, spinal cord injuries or complications related with transoesophageal stimulation. Transcranial motor-evoked potential could not be monitored up to the end of surgery in 3 patients for unknown reasons, 2 of whom from the beginning. Transoesophageal motor-evoked potential became non-evocable after manipulation of a transoesophageal echo probe in 2 patients. Strenuous movement of the upper limbs during transoesophageal stimulation was observed in 3 patients. In 14 patients who successfully completed both monitoring methods up to the end of surgery (11 thoraco-abdominal and 3 descending aortic repair), the final results were judged as false positives in 6 by transcranial stimulation and in 1 by transoesophageal stimulation. The stimulation intensity was significantly lower and the upper limb amplitude was significantly higher by transoesophageal stimulation, while the lower limb amplitude was comparable.CONCLUSIONS: Transoesophageal motor-evoked potential monitoring is clinically feasible and safe with a low false positive rate. A better electrode design is required to avoid its migration by transoesophageal echo manipulation. Further studies may be warranted.Clinical registration number: UMIN000022320.